Collier, P. N., Twin, H. C., Knegtel, R. M. A., Boyall, D., Brenchley, G., Davis, C. J., . . . Jimenez, J. (2019). Discovery of Selective, Orally Bioavailable Pyrazolopyridine Inhibitors of Protein Kinase Cθ (PKCθ) That Ameliorate Symptoms of Experimental Autoimmune Encephalomyelitis. ACS Med Chem Lett.
Citação norma ChicagoCollier, Philip N., et al. "Discovery of Selective, Orally Bioavailable Pyrazolopyridine Inhibitors of Protein Kinase Cθ (PKCθ) That Ameliorate Symptoms of Experimental Autoimmune Encephalomyelitis." ACS Med Chem Lett 2019.
Citação norma MLACollier, Philip N., et al. "Discovery of Selective, Orally Bioavailable Pyrazolopyridine Inhibitors of Protein Kinase Cθ (PKCθ) That Ameliorate Symptoms of Experimental Autoimmune Encephalomyelitis." ACS Med Chem Lett 2019.